Japan Approves First Coronavirus Vaccine But Hurdles Ahead?
Pfizer Gets Nod But Challenges Ahead?
Japanese authorities have issued their first approval for a coronavirus vaccine, to Pfizer/BioNTech’s mRNA product Comirnaty, but public vaccine hesitancy and logistics challenges could be hurdles to achieving high administration rates and effective herd immunity.
